Cancer drug shows promise in Parkinson's disease safety trial
A small clinical trial of nilotinib in people with Parkinson's disease finds that the cancer drug is reasonably safe and holds promise as a therapy.
Source: Parkinson's Disease News From Medical News Today - Category: Neurology Tags: Parkinson's Disease Source Type: news
More News: Cancer | Cancer & Oncology | Clinical Trials | Neurology | Nilotinib | Parkinson's Disease | Tasigna